# Safety Study of Whole Body Hyperthermia for Advanced Cancer

> **NCT04467593** · NA · COMPLETED · sponsor: **ElmediX** · enrollment: 16 (actual)

## Conditions studied

- Advanced Cancer
- Pancreatic Cancer Metastatic

## Interventions

- **DEVICE:** Whole body hyperthermia
- **DRUG:** Standard of Care (SOC) chemotherapy according to the NCCN guidelines.

## Key facts

- **NCT ID:** NCT04467593
- **Lead sponsor:** ElmediX
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-28
- **Primary completion:** 2024-12-25
- **Final completion:** 2024-12-25
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04467593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04467593, "Safety Study of Whole Body Hyperthermia for Advanced Cancer". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT04467593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*